The evolving role of targeted biological agents in the management of indolent B-cell lymphomas.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 12, p. 329, doi. 10.1177/2040620717738740
- By:
- Publication type:
- Article
Works matching IS 20406207 AND DT 2017 AND VI 8 AND IP 12
Results: 3
1
2
Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 12, p. 345, doi. 10.1177/2040620717737701
- By:
- Publication type:
- Article
3
The role of oral anticoagulant therapy in patients with acute coronary syndrome.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 12, p. 353, doi. 10.1177/2040620717733691
- By:
- Publication type:
- Article